Tiotropium does not affect lower urinary tract functions in COPD patients with benign prostatic hyperplasia

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 6, 2008, Pages 879-883

  Miyazaki, Hiroo ^a   Suda, Takafumi ^a   Otsuka, Atsushi ^a   Nagata, Masao ^a   Ozono, Seiichiro ^a   Hashimoto, Dai ^a   Nakamura, Yutaro ^a   Inui, Naoki ^a   Nakamura, Hirotoshi ^a   Chida, Kingo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Benign prostatic hyperplasia; COPD; Tiotropium; Urodynamics

Indexed keywords

TIOTROPIUM BROMIDE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG SAFETY; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; URINE RETENTION; URODYNAMICS;

ADMINISTRATION, INHALATION; AGED; CHOLINERGIC ANTAGONISTS; HUMANS; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SCOPOLAMINE DERIVATIVES; URINARY RETENTION; URINARY TRACT; URODYNAMICS;

EID: 56949094751     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.10.001     Document Type: Article

References (17)

1. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349 (1997) 1436-1442
2. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
3. Disse B., Speck G.A., Rominger K.L., Witek Jr. T.J., and Hammer R. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 64 (1999) 457-464
4. Maesen F.P., Smeets J.J., Sledsens T.J., Wald F.D., and Cornelissen P.J. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch study group. Eur Respir J 8 (1995) 1506-1513
5. Casaburi R., Mahler D.A., Jones P.W., Wanner A., San P.G., ZuWallack R.L., et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19 (2002) 217-224
6. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
7. Brown J.H., and Taylor P. Muscarinic receptor agonists and antagonists. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. (2006), McGraw-Hill, New York 183-200
8. Spiriva Handihaler tiotropium bromide inhalation powder [US package insert]. Ingelheim, Germany: Boehringer Ingelheim International GmbH; 2004.
9. Kesten S., Jara M., Wentworth C., and Lanes S. Pooled clinical trial analysis of tiotropium safety. Chest 130 (2006) 1695-1703
10. Barr R.G., Bourbeau J., Camargo C.A., and Ram F.S. Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis. Thorax 61 (2006) 854-862
11. Casaburi R., Briggs Jr. D.D., Donohue J.F., Serby C.W., Menjoge S.S., and Witek Jr. T.J. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. Chest 118 (2000) 1294-1302
12. van Noord J.A., Bantje T.A., Eland M.E., Korducki L., and Cornelissen P.J. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. Throrax 55 (2000) 289-294
13. Donohue J.F., van Noord J.A., Bateman E.D., Langley S.J., Lee A., Witek Jr. T.J., et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 122 (2002) 47-55
14. Cockett A.T., Aso Y., Denis L., Khoury S., Barry M., Carlton C.E., et al. World health organization consensus committee recommendations concerning the diagnosis of BPH. Prog Urol 1 (1991) 957-972
15. Barnes P.J. The pharmacological properties of tiotropium. Chest 117 (2000) 63S-66S
16. Kalra L., and Bone M.F. The effect of nebulized bronchodilator therapy on intraocular pressures in patients with glaucoma. Chest 93 (1988) 739-741
17. Oksuz H., Tamer C., Akoqlu S., and Duru M. Acute angle-closure glaucoma precipitated by local tiotropium absorption. Pulm Pharmacol Ther 6 (2007) 627-628